161 related articles for article (PubMed ID: 8965348)
41. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?
Jansson T; Westlin JE; Ahlström H; Lilja A; Långström B; Bergh J
J Clin Oncol; 1995 Jun; 13(6):1470-7. PubMed ID: 7751894
[TBL] [Abstract][Full Text] [Related]
42. Positron emission tomography, bronchogenic carcinoma, and the adrenals.
Lamki LM
AJR Am J Roentgenol; 1997 May; 168(5):1361-2. PubMed ID: 9129445
[No Abstract] [Full Text] [Related]
43. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.
Patz EF; Lowe VJ; Hoffman JM; Paine SS; Burrowes P; Coleman RE; Goodman PC
Radiology; 1993 Aug; 188(2):487-90. PubMed ID: 8327702
[TBL] [Abstract][Full Text] [Related]
44. [Evaluation of pulmonary lesions with positron emission tomography].
Knopp MV; Bischoff HG
Radiologe; 1994 Oct; 34(10):588-91. PubMed ID: 7816916
[TBL] [Abstract][Full Text] [Related]
45. Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG).
Hubner KF; McDonald TW; Niethammer JG; Smith GT; Gould HR; Buonocore E
Gynecol Oncol; 1993 Nov; 51(2):197-204. PubMed ID: 8276294
[TBL] [Abstract][Full Text] [Related]
46. [Contribution of positron emission tomography for the management of lung cancer].
Bury T; Rigo P
Rev Pneumol Clin; 2000 Apr; 56(2):125-31. PubMed ID: 10810198
[TBL] [Abstract][Full Text] [Related]
47. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities.
Lowe VJ; Hoffman JM; DeLong DM; Patz EF; Coleman RE
J Nucl Med; 1994 Nov; 35(11):1771-6. PubMed ID: 7965154
[TBL] [Abstract][Full Text] [Related]
48. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG.
Kubota R; Kubota K; Yamada S; Tada M; Takahashi T; Iwata R; Tamahashi N
J Nucl Med; 1995 Mar; 36(3):484-92. PubMed ID: 7884515
[TBL] [Abstract][Full Text] [Related]
49. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
Brock CS; Meikle SR; Price P
Eur J Nucl Med; 1997 Jun; 24(6):691-705. PubMed ID: 9169580
[TBL] [Abstract][Full Text] [Related]
50. [A useful method to evaluate 11C-methionine uptake using positron emission tomography: determination of the optimal scanning time for evaluation and a comparison between the tumor-to-muscle ratio and the distribution absorption ratio].
Sasaki M; Akashi Y; Ichiya Y; Kuwabara Y; Yoshida T; Fukumura T; Masuda K
Kaku Igaku; 1994 Dec; 31(12):1547-52. PubMed ID: 7861654
[TBL] [Abstract][Full Text] [Related]
51. [The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
Granov AM; Tiushin LA; Tlostanova MS; Kostenikov NA; Ryzhkova DV; Savello VE; Stanzhevskiĭ AA
Vopr Onkol; 2003; 49(5):563-73. PubMed ID: 14682126
[TBL] [Abstract][Full Text] [Related]
52. PET scans of abdominal malignancy.
Blahd WH; Brown CV; Khonsary SA; Farahi JB; Quinones N; Ribe JY; Coyle JJ; Glass EC; Mandelkern MA
World J Surg; 1996 Feb; 20(2):245-7. PubMed ID: 8661826
[TBL] [Abstract][Full Text] [Related]
53. Imaging metastatic testicular germ cell tumours with 18FDG positron emission tomography: prospects for detection and management.
Wilson CB; Young HE; Ott RJ; Flower MA; Cronin BF; Pratt BE; McCready VR; Horwich A
Eur J Nucl Med; 1995 Jun; 22(6):508-13. PubMed ID: 7556294
[TBL] [Abstract][Full Text] [Related]
54. Development of oncology protocol using fluorine-18-FDG: one center's experience.
Cronin V; Galantowicz P; Nabi HA
J Nucl Med Technol; 1997 Mar; 25(1):66-9. PubMed ID: 9239608
[TBL] [Abstract][Full Text] [Related]
55. [Problems of differential diagnosis in the diagnosis of mediastinal and pulmonary metastases with F-a8-FDG PET].
Adams S; Nickel E; Hör G
Nuklearmedizin; 2000 Aug; 39(5):N83-4. PubMed ID: 10984898
[No Abstract] [Full Text] [Related]
56. [Diagnosis of cancers by FDG-PET].
Ichiya Y
Fukuoka Igaku Zasshi; 1997 Jan; 88(1):7-10. PubMed ID: 9091463
[No Abstract] [Full Text] [Related]
57. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.
Rigo P; Paulus P; Kaschten BJ; Hustinx R; Bury T; Jerusalem G; Benoit T; Foidart-Willems J
Eur J Nucl Med; 1996 Dec; 23(12):1641-74. PubMed ID: 8929320
[TBL] [Abstract][Full Text] [Related]
58. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography of pulmonary adenocarcinoma.
Kaji M; Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
Ann Thorac Surg; 2007 Jan; 83(1):312-4. PubMed ID: 17184694
[TBL] [Abstract][Full Text] [Related]
59. [18FDG in the primary staging of lung tumors. Results with a gamma camera and a 511 keV collimator].
Trampert L; Holle LH; Berberich R; Alexander C; Ukena D; Ruth T; Sybrecht GW; Oberhausen E
Nuklearmedizin; 1995 Jun; 34(3):79-86. PubMed ID: 7630746
[TBL] [Abstract][Full Text] [Related]
60. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study.
Tahara T; Ichiya Y; Kuwabara Y; Otsuka M; Miyake Y; Gunasekera R; Masuda K
J Comput Assist Tomogr; 1989; 13(5):829-31. PubMed ID: 2789238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]